# FDA 483 - Continental Services Group, Inc. - July 09, 2019

Source: https://www.keypedia.com/records/483/continental-services-group-inc/0cf3e35c-a346-4edd-a397-675618242d39

> FDA 483 for Continental Services Group, Inc. on July 09, 2019. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Continental Services Group, Inc.
- Inspection Date: 2019-07-09
- Product Type: biologics
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: An FDA inspection of Continental Services Group, Inc., a blood bank in Miami, FL, revealed two significant observations. The firm failed to maintain aseptic methods during blood collection, specifically during venipuncture, and also failed to provide adequate private and acoustically protected spaces for donor eligibility examinations.

## Related Officers

- [Annette Melendez](https://www.keypedia.com/people/annette-melendez/bc1a065d-6408-4c4b-9dcf-c6884e8a75c4)

Company: https://www.keypedia.com/companies/continental-services-group-inc/6a7a7180-4020-4fc8-a2f2-ca4ab032c3a4

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6